Sandeep Arora

1.1k citations

43 papers · 790 indexed · h-index 16

Co-authors: Tapan Behl Saim Kashmiri Arun Kumar Simona Bungău Sukhbir Singh Thakur Gurjeet Singh Neelam Sharma Ashish K. Rehni
Topics: Drug Solubulity and Delivery Systems (4 papers)Advanced Drug Delivery Systems (4 papers)Adipokines, Inflammation, and Metabolic Diseases (3 papers)
Cited by: Pharmaceutical Science Rehabilitation Pharmacology
Journals: SHILAP Revista de lepidopterologíaCritical Reviews in Food Science and Nutrition Journal of the Academy of Marketing Science
Partner nations: India Romania Bangladesh

In The Last Decade

Sandeep Arora

43 papers receiving 773 citations

Peers

Countries citing papers authored by Sandeep Arora

Since Specialization

Citations

This map shows the geographic impact of Sandeep Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandeep Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandeep Arora more than expected).

Fields of papers citing papers by Sandeep Arora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandeep Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandeep Arora. The network helps show where Sandeep Arora may publish in the future.

Co-authorship network of co-authors of Sandeep Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Sandeep Arora. A scholar is included among the top collaborators of Sandeep Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandeep Arora. Sandeep Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-Amyloid-β Immunotherapy: A Leading Novel Avenue for Alzheimer'sDisease 2022 ·Mini-Reviews in Medicinal Chemistry ·(unknown),(unknown),(unknown),(unknown),Sandeep Arora,Vishnu Nayak Badavath	1
2	Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients 2022 ·SHILAP Revista de lepidopterología ·Murlidhar Rajagopalan,Sunil Dogra,Kiran Godse,Bikash Ranjan Kar,(unknown),Shekhar Neema,Abir Saraswat,(unknown),Nina Madnani,(unknown),(unknown),(unknown),Sandeep Arora,(unknown)	3
3	Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders 2022 ·Bioorganic Chemistry ·Sukhbir Singh,Ajmer Singh Grewal,(unknown),Neelam Sharma,Bhawna Chopra,Ashwani K. Dhingra,Sandeep Arora,(unknown),Viney Lather	42
4	Mechanistic Interventions of Selected Ocimum Species in Management of Diabetes, Obesity and Liver Disorders: Transformative Developments from Preclinical to Clinical Approaches 2021 ·Biointerface Research in Applied Chemistry ·Nikhil Garg,Thakur Uttam Singh,Heena Khan,Sandeep Arora,Amarjot Kaur,Ashi Mannan,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	18
5	Quality by Design Approach for Formulation and Optimization of Microparticles Based Inhalable Phytopharmaceuticals of Trigonella Foenum-Graecum and Alpinia Galanga 2021 ·Biointerface Research in Applied Chemistry ·(unknown),Neelam Sharma,Sandeep Arora,Tapan Behl,Sukhbir Singh,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	1
6	Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management 2021 ·Pharmaceutics ·Sukhbir Singh,Neelam Sharma,Tapan Behl,(unknown),(unknown),Kanika Garg,(unknown),Sandeep Arora,Md. Shah Amran,Ahmed A. H. Abdellatif,Anwar L. Bilgrami,Ghulam Md Ashraf,Md. Sohanur Rahman	15
7	Emerging Therapeutic Effects of Herbal Plants in Rheumatoid Arthritis 2020 ·Endocrine Metabolic & Immune Disorders - Drug Targets ·Rashita Makkar,Tapan Behl,Arun Kumar,(unknown),Sandeep Arora	10
8	Mechanistic insights into the role of pyroptosis in rheumatoid arthritis 2020 ·Current Research in Translational Medicine ·Swati Chadha,Tapan Behl,Simona Bungău,Arun Kumar,Rashmi Arora,Amit Gupta,Md. Sahab Uddin,Gökhan Zengin,Lotfi Aleya,Dhruv Setia,Sandeep Arora	35
9	Understanding the Role of Inflammasomes in Rheumatoid Arthritis 2020 ·Inflammation ·Rashita Makkar,Tapan Behl,Simona Bungău,Arun Kumar,Sandeep Arora	19
10	Molecular insights into therapeutic promise of targeting of Wnt/β-catenin signaling pathway in obesity 2020 ·Molecular Biology Reports ·(unknown),Tapan Behl,Simona Bungău,Md. Sahab Uddin,Gökhan Zengin,Sandeep Arora	9
11	Protective Role of Herbal Drugs in Diabetic Neuropathy: An Updated Review 2018 ·Eshita Sharma,Tapan Behl,Monika Sachdeva,Rashita Makkar,Sandeep Arora	2
12	Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorders 2017 ·(unknown),(unknown),Anurag Sharma,Sandeep Arora,Amarjot Kaur Grewal,Thakur Gurjeet Singh	1
13	A Review on Medication Errors 2015 ·(unknown),Amit Sharma,Sandeep Arora	1
14	A Review on Role of Advanced Glycation End products (AGEs) in Rheumatoid Arthritis 2015 ·(unknown),Sandeep Arora,(unknown),(unknown)	3
15	Modeling and phylogenetic analysis of cytosolic ascorbate peroxidase (OsAPX1) from rice reveal signature motifs that may play a role in stress tolerance 2014 ·Bioinformation ·Saurabh Pandey,Yogesh Kumar Negi,(unknown),(unknown),Sandeep Arora,Tanushri Kaul	1
16	Therapeutic Effect ofFicus lacorAerial Roots of Various Fractions on Adjuvant-Induced Arthritic Rats 2013 ·PubMed ·Rakesh K. Sindhu,Sandeep Arora	4
17	Pharmacological modulation of farnesyltransferase subtype I attenuates mecamylamine-precipitated nicotine withdrawal syndrome in mice 2013 ·Behavioural Pharmacology ·Thakur Gurjeet Singh,Ashish K. Rehni,Sandeep Arora	6
18	Ocular insert for sustained delivery of gatifloxacin sesquihydrate: Preparation and evaluations 2012 ·International Journal of Pharmaceutical Investigation ·P.P. Pawar,(unknown),Sandeep Arora	35
19	Involvement of src-kinase activation in ischemic preconditioning induced protection of mouse brain 2011 ·Life Sciences ·Ashish K. Rehni,Thakur Gurjeet Singh,(unknown),Sandeep Arora	16
20	Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism 2009 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Ashish K. Rehni,Thakur Gurjeet Singh,Nirmal Singh,Sandeep Arora	57

About Sandeep Arora

Sandeep Arora is a scholar working on Pharmaceutical Science, Medical Laboratory Technology and Complementary and alternative medicine, having authored 43 papers that have together received 790 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (4 papers), Advanced Drug Delivery Systems (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Pharmaceutical Science (55 citations), Rehabilitation (59 citations) and Pharmacology (47 citations). Sandeep Arora has collaborated with scholars based in India, Romania and Bangladesh. Frequent co-authors include Tapan Behl, Saim Kashmiri, Arun Kumar, Simona Bungău, Sukhbir Singh, Thakur Gurjeet Singh, Neelam Sharma, Ashish K. Rehni, Swati Chadha and Nirmal Singh. Their work appears in journals such as SHILAP Revista de lepidopterología, Critical Reviews in Food Science and Nutrition and Journal of the Academy of Marketing Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact